PARATEK Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PARATEK, and when can generic versions of PARATEK drugs launch?
PARATEK has two approved drugs.
There are nine US patents protecting PARATEK drugs.
There are two hundred and twenty-two patent family members on PARATEK drugs in forty countries.
Drugs and US Patents for PARATEK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Paratek Pharms Inc | NUZYRA | omadacycline tosylate | POWDER;INTRAVENOUS | 209817-001 | Oct 2, 2018 | RX | Yes | Yes | 9,265,740 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Paratek Pharms Inc | NUZYRA | omadacycline tosylate | TABLET;ORAL | 209816-001 | Oct 2, 2018 | RX | Yes | Yes | 8,383,610 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Paratek Pharms Inc | NUZYRA | omadacycline tosylate | TABLET;ORAL | 209816-001 | Oct 2, 2018 | RX | Yes | Yes | 10,111,890 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Paratek Pharms Inc | NUZYRA | omadacycline tosylate | POWDER;INTRAVENOUS | 209817-001 | Oct 2, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PARATEK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Paratek Pharms Inc | NUZYRA | omadacycline tosylate | POWDER;INTRAVENOUS | 209817-001 | Oct 2, 2018 | 7,326,696 | ⤷ Try a Trial |
Paratek Pharms Inc | NUZYRA | omadacycline tosylate | TABLET;ORAL | 209816-001 | Oct 2, 2018 | 7,326,696 | ⤷ Try a Trial |
Paratek Pharms Inc | NUZYRA | omadacycline tosylate | TABLET;ORAL | 209816-001 | Oct 2, 2018 | 9,365,500 | ⤷ Try a Trial |
Paratek Pharms Inc | NUZYRA | omadacycline tosylate | POWDER;INTRAVENOUS | 209817-001 | Oct 2, 2018 | 9,365,500 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PARATEK Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
New Zealand | 598154 | ⤷ Try a Trial |
Canada | 2719751 | ⤷ Try a Trial |
China | 102015602 | ⤷ Try a Trial |
Eurasian Patent Organization | 200802365 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.